A8DG50 (A8DG50_9HEPC) hepatitis C virus genotype 1a
Genome polyprotein UniProtKBInterProInteractive Modelling
3011 aa; Sequence (Fasta)
No models have been built for this target sequence.
Available Structures
26 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
Crystal structure of HCV NS3/4A protease in complex with N-terminal product 5A5B |
Heteromer B3TKQ3; | 1×SO4; 1×ZN; | ||||
Assess | ||||||
Avoiding drug resistance against HCV NS3/4A protease inhibitors |
Heteromer Q9WPH5; | 1×ZN; | ||||
Assess | ||||||
Crystal structure of HCV NS3/4A protease in complex with N-terminal product 4B5A |
Heteromer B3TKQ3; | 1×SO4; 1×ZN; | ||||
Assess | ||||||
Crystal structure of NS3/4A protease variant A156T in complex with vaniprevir | monomer | 1×SU3; 1×GOL; 2×SO4; 1×ZN; | ||||
Assess | ||||||
Crystal structure of NS3/4A protease in complex with vaniprevir | monomer | 1×SU3; 2×SO4; 1×ZN; | ||||
Assess | ||||||
Crystal structure of NS3/4A protease in complex with Telaprevir | monomer | 1×SV6; 1×GOL; 1×SO4; 1×ZN; | ||||
Assess | ||||||
Crystal structure of NS3/4A protease variant R155K in complex with Telaprevir | monomer | 1×SV6; 1×SO4; 1×ZN; | ||||
Assess | ||||||
Crystal structure of NS3/4A protease variant D168A in complex with vaniprevir | monomer | 1×SU3; 4×SO4; 1×ZN; | ||||
Assess | ||||||
Crystal structure of NS3/4A protease variant A156T in complex with Telaprevir | monomer | 1×SV6; 1×GOL; 1×SO4; 1×ZN; | ||||
Assess | ||||||
Crystal structure of NS3/4A protease variant A156T in complex with MK-5172 | monomer | 1×SUE; 1×SO4; 1×ZN; | ||||
Assess | ||||||
Crystal structure of NS3/4A protease in complex with MK-5172 | monomer | 1×SUE; 1×SO4; 1×ZN; | ||||
Assess | ||||||
Crystal structure of NS3/4A protease variant D168A in complex with Telaprevir | monomer | 1×SV6; 1×GOL; 1×ZN; | ||||
Assess | ||||||
Crystal structure of NS3/4A protease variant D168A in complex with MK-5172 | monomer | 1×SUE; 1×ZN; | ||||
Assess | ||||||
Crystal structure of NS3/4A protease variant R155K in complex with MK-5172 | monomer | 1×SUE; 1×ZN; | ||||
Assess | ||||||
Crystal structure of hepatis c virus protease (ns3) complexed with bms-650032 aka n-(tert-butoxycar… | monomer | 1×2R9; 1×ZN; | ||||
Assess | ||||||
Molecular mechanisms of viral and host-cell substrate recognition by HCV NS3/4A protease | monomer | 1×ZN; | ||||
Assess | ||||||
Crystal structure of NS3/4A protease variant R155K in complex with danoprevir | monomer | 1×TSV; 1×SO4; 1×ZN; | ||||
Assess | ||||||
Crystal structure of NS3/4A protease variant D168A in complex with danoprevir | monomer | 1×TSV; 4×SO4; 1×ZN; | ||||
Assess | ||||||
Crystal structure of HCV NS3/4A protease in complex with ITMN-191 | monomer | 1×TSV; 1×SO4; 1×ZN; | ||||
Assess | ||||||
Crystal structure of NS3/4A protease variant A156T in complex with danoprevir | monomer | 1×TSV; 2×SO4; 1×ZN; | ||||
Assess | ||||||
Crystal structure of HCV NS3/4A double mutant variant Y56H/D168A in complex with danoprevir | monomer | 1×ZN; 1×SO4; 1×TSV; | ||||
Assess | ||||||
Crystal structure of hepatis c virus protease (ns3) complexed with bms-605339 aka n-(tert-butoxycar… | monomer | 1×2R8; 1×ZN; 1×SO4; 7×GOL; | ||||
Assess | ||||||
Crystal structure of HCV NS3/4A protease variant R155K in complex with Asunaprevir | monomer | 2×SO4; 1×ZN; 1×2R9; | ||||
Assess | ||||||
Crystal structure of HCV NS3/4A D168A protease in complex with NR04-49 | monomer | 1×ZN; 1×XSY; 4×EDO; 1×SO4; | ||||
Assess | ||||||
Crystal structure of HCV NS3/4A D168A protease in complex with NR02-58 | monomer | 1×ARG; 1×ZK7; 1×ZN; | ||||
Assess | ||||||
Crystal Structure of HCV NS3/4A protease in complex with an Asunaprevir P1-P3 macrocyclic analog. | monomer | 1×3M7; 2×SO4; 1×ZN; | ||||
Assess |